Evaluating the Prognostic Value of Stress Echocardiography
Official title: The Prognostic Value of Positive Stress Echocardiography and Its Relationship with Invasive Coronary Angiography: the AMPHIPOLIS Study
Run by Hellenic Society of Cardiology · NCT06839755 · Data updated 2026-11-12
This study is testing if positive stress echocardiography results can help predict serious heart problems in people with coronary artery disease or reduced blood flow to the heart.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 390 (estimated) |
| Sponsor | Hellenic Society of Cardiology Academic / other |
| Locations | 1 site (Athens, Attica) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | January 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 21, 2025 |
| Trial ID | NCT06839755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with recent positive stress echocardiography indicating myocardial ischemia.
✕Probably not a fit
Patients with heart failure requiring viability studies, symptomatic valvular disease, or recent acute coronary syndrome may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the prognostic value of positive stress echocardiography in patients with coronary artery disease or myocardial ischemia. It will enroll 390 patients from 25 echocardiography labs in Greece and Cyprus, who will undergo invasive coronary angiography within six weeks of their positive stress echo. The study will monitor participants for major adverse cardiovascular events and cardiovascular death over a follow-up period of at least 12 months. Additionally, it will explore the relationship between stress echo findings and coronary angiography results.
Why it matters
Potential benefit: If successful, this study could improve the prognostic assessment and management of patients with coronary artery disease.
How similar studies have gone: Previous studies have shown promise in using stress echocardiography for prognostic evaluation, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients with recent stress echocardiography positive for any extent of myocardial ischemia Exclusion Criteria: 1. HFrEF requiring viability study. 2. Any symptomatic valvular disease causing symptoms. 3. Established or suspected cardiomyopathy. 4. Concomitant chronic diseases reducing life expectancy (active cancer, severe liver impairment, auto-immune diseases etc). 5. Recent acute coronary syndrome the last week.
Where it's running
-
Hellenic Society of Cardiology
Athens, Attica, Greece Recruiting
Study contacts
- Principal investigator: Nikolaos Kadoglou — University of Cyprus
- Study coordinator: Nikolaos Kadoglou
- Email: nikoskad@yahoo.com
- Phone: +306973275750
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
COMA.NET: Targeted treatment for coronary microcirculation problems
This trial will test whether tailoring medicines based on intracoronary microvascular testing improves quality of life for people with ischemia but no large artery blockages.
-
Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease
This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Software that analyzes heart CT scans to detect coronary artery disease
This project will test a new software that uses past coronary CT scans to see if it can accurately find blockages and predict which patients might need procedures.
-
Comparing heart imaging techniques for coronary artery disease
This study is testing if a new heart imaging method can better identify problems in patients suspected of having coronary artery disease compared to a traditional imaging technique.
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.